Avricore Health (AVCRF) Cash from Financing Activities (2014 - 2024)
Avricore Health (AVCRF) reported Cash from Financing Activities of $28662.4 for Q3 2024, up 392.55% quarter-over-quarter from -$9797.3 in Q2 2024.
Avricore Health (AVCRF) Cash from Financing Activities (2014 - 2024) Analysis & Trends
Avricore Health (AVCRF) has 11 years of Cash from Financing Activities data on file, last reported at $28662.4 in Q3 2024.
- Cash from Financing Activities for Q3 2024 came in at $28662.4, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $8178.7 (down 95.69% YoY), and the FY2024 annual result was $41340.6, up 31.24% from the prior year.
- Cash from Financing Activities improved to $28662.4 in Q3 2024 per AVCRF's latest filing, from -$9797.3 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $2.0 million in Q1 2021 and troughed at -$10686.4 in Q1 2024.
- A 5-year average of $238130.2 and a median of $28755.3 in 2020 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2021 and 2024: Cash from Financing Activities soared 29339.31% in 2021, then slumped 187.74% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $473420.0 in 2020, then slumped by 87.11% to $61042.5 in 2021, then jumped by 159.33% to $158302.7 in 2022, then sank by 92.95% to $11166.8 in 2023, then surged by 156.68% to $28662.4 in 2024.
- Business Quant data shows AVCRF's Cash from Financing Activities at $28662.4 in Q3 2024, -$9797.3 in Q2 2024, and -$10686.4 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 28,662.39 |
| Sep 30, 2024 | 28,662.39 |
| Jun 30, 2024 | -9,797.28 |
| Jun 30, 2024 | -9,797.28 |
| Mar 31, 2024 | -10,686.43 |
| Mar 31, 2024 | -10,686.43 |
| Jun 30, 2023 | 11,166.79 |
| Jun 30, 2023 | 11,166.79 |
| Mar 31, 2023 | 20,341.65 |
| Mar 31, 2023 | 20,341.65 |
| Dec 31, 2022 | 158,302.73 |
| Dec 31, 2022 | 158,302.73 |
| Sep 30, 2022 | 11,501.19 |
| Sep 30, 2022 | 11,501.19 |
| Mar 31, 2022 | 18,947.41 |
| Mar 31, 2022 | 18,947.41 |
| Dec 31, 2021 | 61,042.45 |
| Dec 31, 2021 | 61,042.45 |
| Sep 30, 2021 | 259,791.70 |
| Sep 30, 2021 | 259,791.70 |